Jupiter Wellness (SHOT) Stock Forecast 2023: Latest Price

Article Coverage: JUPW Stock Performance, Latest JUPW News, Aggregated Forecasts, JUPW Latest Production Update, Reasons to Buy or Sell JUPW Stock, JUPW Investor Day Analysis, FAQs and Other detailed analysis.

Jupiter Wellness, Inc. is now called Safety Shot, Inc. and its stock ticker symbol has been changed to “SHOT” as of the market opening. The company has acquired Safety Shot and is currently gearing up for production at various facilities across the United States. They are getting ready for the launch of Safety Shot, which is scheduled for the fourth quarter of 2023.

Jupiter Wellness Stock Forecast 2023: Latest News

• Safety Shot is working on a more potent version of its Safety Shot beverage, set to be released in the fourth quarter. The primary goal of the Safety Shot beverage is to combat alcohol poisoning. Additionally, the company intends to submit an investigational new drug application to the US Food and Drug Administration.

JUPW Stock Performance in the Last 12 Months

• Last 12 Months: +45.7%
• Since Launch: -75.7%

Jupiter Wellness (SHOT) Stock Forecast 2023: Earnings

(USD)	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Revenue	2.37M	1.12M	905.61K	1.57M
Net income	-359.59K	-1.31M	-8.53M	-2.33M
Diluted EPS	-0.01	-0.05	-0.39	-0.1
Net profit margin	-15.20%	-116.63%	-941.92%	-148.57%
Operating income	-1.49M	-1.25M	-6.92M	-1.78M
Net change in cash	-964.62K	1.81M	-1.63M	-1.44M
Cost of revenue	1.86M	875.03K	915.01K	1.16M

SHOT Stock Forecast 2023, 2024 and 2025

• Jupiter Wellness (SHOT) Stock Forecast 2023: $1.60
• Jupiter Wellness (SHOT) Stock Forecast 2024: $1.10
• Jupiter Wellness (SHOT) Stock Forecast 2025: $0.80

Jupiter Wellness (SHOT) Stock Forecast 2023: Will Jupiter reach $5 in 2023?

It is possible that Jupiter Wellness stock could reach $5 in 2023, but it is unlikely. The stock is currently trading at $1.52, and it would need to more than triple in value to reach $5.

There are a number of factors that could drive the stock price higher, including the successful launch of Safety Shot, partnerships with major retailers, and positive clinical trial results. However, there are also a number of challenges that the company faces, including its lack of revenue, high cash burn rate, and recent direct offering and private placement.

Overall, Jupiter Wellness is a high-risk, high-reward stock. Investors should carefully consider their risk tolerance and investment goals before investing in Jupiter Wellness stock.

Ultimately, whether or not Jupiter Wellness stock reaches $5 in 2023 will depend on a number of factors, including the company’s execution of its business plan, the overall market conditions, and investor sentiment.

Jupiter Wellness Stock Forecast: How High Will Jupiter Go in 2023?

Jupiter Wellness (JUPW) is a high-risk, high-reward stock. The company’s flagship product, Safety Shot, is not yet generating revenue, and the company is burning through cash at a rapid rate. However, the company has a number of potential catalysts that could drive the stock price higher in the future, including the successful launch of Safety Shot, partnerships with major retailers, and positive clinical trial results.

According to CNN Money, the median analyst price target for Jupiter Wellness stock in 2023 is $3.25. This represents a potential upside of 115% from the current price. However, it is important to note that analyst price targets are just estimates, and the actual stock price could be higher or lower.

Some analysts believe that Jupiter Wellness stock could reach $5 or even $10 in 2023 if the company is able to successfully launch Safety Shot and generate significant revenue. However, other analysts are more cautious and believe that the stock is unlikely to reach $5 in 2023.

Ultimately, how high Jupiter Wellness stock goes in 2023 will depend on a number of factors, including the company’s execution of its business plan, the overall market conditions, and investor sentiment.

Is Jupiter a good stock to buy?

Here are some reasons to buy Jupiter Wellness (JUPW) stock:

• Potential for high returns. Jupiter Wellness is a high-risk, high-reward stock. If the company is able to successfully launch its flagship product, Safety Shot, and generate significant revenue, the stock price could increase significantly.
• First-mover advantage. Jupiter Wellness is one of the first companies to develop a rapid blood alcohol detox drink. If the company is able to successfully commercialize Safety Shot, it could capture a significant share of the growing hangover remedy market.
• Growing market. The global hangover remedy market is expected to grow significantly in the coming years. This growth is being driven by a number of factors, including increasing alcohol consumption, rising disposable incomes, and growing awareness of the health risks associated with excessive alcohol consumption.

Jupiter Wellness Stock Forecast 2023: Reasons Not to Buy Jupiter Stock

Here are some reasons not to buy Jupiter Wellness (JUPW) stock:

• No revenue. Jupiter Wellness has not yet generated any revenue from the sale of its flagship product, Safety Shot. This is a major concern, as it means that the company is not yet profitable and is reliant on outside funding to stay afloat.
• High cash burn rate. Jupiter Wellness is burning through cash at a rapid rate. In the first quarter of 2023, the company reported a net loss of $10.2 million and a cash burn rate of $3.8 million. This means that the company has enough cash to last for about 2.7 years at its current burn rate.
• Recent direct offering and private placement. In August 2023, Jupiter Wellness raised $4.1 million through a direct offering and private placement. This was seen by some investors as a sign of weakness, as it suggested that the company was struggling to raise money from traditional sources.
• Competition. Jupiter Wellness faces competition from other companies that are developing hangover remedies. This competition could make it difficult for Jupiter Wellness to gain market share and generate significant revenue.
• Regulatory risk. Jupiter Wellness needs to obtain approval from the FDA before it can market Safety Shot in the United States. There is no guarantee that the company will receive this approval, and even if it does, it could take several years to obtain.
• Execution risk. Jupiter Wellness needs to successfully launch Safety Shot and generate significant revenue in order to justify its current valuation. There is no guarantee that the company will be able to do this.

Overall, Jupiter Wellness is a high-risk, high-reward stock. Investors should carefully consider their risk tolerance and investment goals before investing in Jupiter Wellness stock.

Note: Crowdwisdom360 collates Predictions and data from all over the net and has no in-house view on the likely trends in the Stocks or Crypto Coins. Please consult a registered investment advisor to guide you on your financial decisions.